PROSTATE CANCER RESEARCH INC (EIN 853336070) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

JOHN WETHERINGTON

Phone

2037355447

Tax Period

2023-01-01 to 2023-12-31

PROSTATE CANCER RESEARCH INC, founded in 2020, is a micro nonprofit in the Medical Research sector that reported $23K in total revenue in fiscal year 2023. Expenses of $421K exceeded revenue, resulting in a 1755% operating deficit.

Mission

PROSTATE CANCER RESEARCH, INC. (THE ORGANIZATION) IS A NON-PROFIT ORGANIZATION FORMED SEPTEMBER 28, 2020 TO HELP DEVELOP AND DELIVER BREAKTHROUGH MEDICINES AND TREATMENTS FOR A WORLD WHERE PEOPLE ARE FREE FROM THE IMPACT OF PROSTATE CANCER. PROSTATE CANCER RESEARCH, INC'S GOAL IS TO INVEST IN THE SCIENCE, RESEARCH AND MEDICAL BREAKTHROUGHS FOR THE FUTURE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $22,687

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $22,687

Expense Breakdown

Grants Paid $220,399

Salaries & Benefits $126,397

Fundraising Expenses $120,933

Program Expenses $240,048

Other Expenses $73,943

TOTAL EXPENSES $420,739

Year-over-Year Comparison

	2023	2022	Change
Revenue	$22,687	N/A	N/A
Expenses	$420,739	$293,728	+0.4%
Net Income	$-398,052	$-293,728	+0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHELLE MCGUINNESS	DIRECTOR	1.00	Director	$0	$0	$0
ADAM SCHAYOWITZ	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTOPHER SHEPARD	DIRECTOR	1.00	Director	$0	$0	$0
SUMAN SHIRODKAR	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTINA RENNER-THOMAS	DIRECTOR	1.00	Director	$0	$0	$0
CATHERINE C TURKEL	DIRECTOR	1.00	Director	$0	$0	$0
RICHARD COLLIER	PRESIDENT	5.00	Officer	$0	$0	$0
JOHN WETHERINGTON	TREASURER	5.00	Officer	$0	$0	$0
OLIVER KEMP	SECRETARY	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$22,687	$420,739	$30,551	$-398,052
2022	No data	$293,728	$29,232	No data
2021	$33,109	$179,095	$17,070	$-145,986

PROSTATE CANCER RESEARCH INC